UVIRA, DR Congo, Dec. 15 (Xinhua) -- In Uvira, a strategic city in eastern Democratic Republic of the Congo (DRC), streets are being swept, shops are cautiously reopening, and residents are stepping ...

Investing.com - Raymond James在 Palvella Therapeutics (NASDAQ:PVLA) 公布积极的2期临床试验结果后，重申了其强力买入评级和143.00美元的目标价。该股票年初至今已取得惊人的721.5%回报率，目前股价为101.39美元，略低于其52周高点106.71美元。